Large scale manufacturing of B43(anti-CD19)-genistein for clinical trials in leukemia and lymphoma.

Myers, D E

Large scale manufacturing of B43(anti-CD19)-genistein for clinical trials in leukemia and lymphoma. [electronic resource] - Leukemia & lymphoma Apr 1998 - 329-38 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1042-8194

10.3109/10428199809068569 doi


Antibodies, Monoclonal
Antineoplastic Agents--therapeutic use
Genistein--therapeutic use
Humans
Immunoconjugates--chemistry
Leukemia--therapy
Lymphoma--therapy
Tumor Cells, Cultured--drug effects